Published July 11, 2008 | Version v1
Journal article

NFBD1/MDC1 stabilizes oncogenic MDM2 to contribute to cell fate determination in response to DNA damage

  • 1. Department of General Surgery, Hokkaido University School of Medicine, Kita-ku, Sapporo 060-8638 (Japan)
  • 2. Division of Biochemistry, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuoh-ku, Chiba 260-8717 (Japan)

Description

In response to DNA damage, NFBD1/MDC1 induces the accumulation of DNA repair machinery such as MRN complex at the sites of damaged DNA to form nuclear foci. In this study, we found that NFBD1 directly interacts with MDM2 and increases its stability. During adriamycin (ADR)-mediated apoptosis, expression levels of NFBD1 reduced in association with the down-regulation of MDM2. Enforced expression of NFBD1 resulted in a significant stabilization of MDM2. Consistent with these observations, siRNA-mediated knockdown of the endogenous NFBD1 decreased the amounts of the endogenous MDM2. Immunoprecipitation and in vitro pull-down assays demonstrated that NFBD1 interacts with MDM2 through its COOH-terminal BRCT domains. In accordance with our recent results, enforced expression of NFBD1 rendered cells resistant to DNA damage. Similar results were also obtained in cells expressing exogenous MDM2. Taken together, our present findings suggest that NFBD1-mediated stabilization contributes to cell survival in response to DNA damage

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2008.04.155

Additional details

Identifiers

DOI
10.1016/j.bbrc.2008.04.155;
PII
S0006-291X(08)00865-6;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
371
Journal Issue
4
Journal Page Range
p. 829-833
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
40023673
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
APOPTOSIS; DNA; DNA DAMAGES; DNA REPAIR; DOXORUBICIN; IN VITRO; STABILIZATION
Descriptors DEC
ANTI-INFECTIVE AGENTS; ANTIBIOTICS; ANTINEOPLASTIC DRUGS; BIOLOGICAL RECOVERY; BIOLOGICAL REPAIR; DRUGS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; REPAIR

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.